Phase IB Study of Sorafenib and Evofosfamide in Patients with Advanced Hepatocellular and Renal Cell Carcinomas (NCCTG N1153, Alliance)
- Citation:
- Invest New Drugs vol 39 (4) 1072-80
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 2486
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Threshold Pharmaceuticals
- Grants:
- U10CA180821, U10CA180882, UG1CA232760, DP2CA195764, K12CA090628
- Corr. Author:
- Authors:
- Nguyen H Tran Nathan R Foster Amit Mahipal Thomas Byrne Joleen Hubbard Alvin Silva Kabir Mody Steven Alberts Mitesh J. Borad
- Networks:
- LAPS-MA036, LAPS-MN026, METROMIN
- Study
- NCCTG-N1153
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords: